Screener / SEC EDGAR /CIK 0000914156 /10-K filed Feb 27, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Instruments

UFP Technologies Inc UFPT

Compare with peers Embed
FY2025 at a glance

Sales up 19.5%

XBRL, from each 10-K
RevenueStatements
$602.8M from $504.4M in FY2024
FY2016FY2025
Net incomeStatements
$68.3M from $59.0M in FY2024
FY2016FY2025
EPS (diluted)Statements
$8.75 from $7.58 in FY2024
FY2016FY2025
Operating marginStatements
15.3% from 16.0% in FY2024
FY2016FY2025
Total debtStatements
$135.5M from $189.4M in FY2024
FY2016FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (43)
EPS (ttm)
9.79
Sales (ttm)
649.5M
Net income (ttm)
76.5M
Sales growth
+19.5%
EPS growth
+15.4%
Sales Q/Q
+11.6%
Free cash flow
-
Gross margin
28.9%
Oper. margin
15.5%
Net margin
11.8%
FCF margin
-
R&D / sales
1.4%
Dividend
-
Debt/Eq
0.20
Curr. ratio
2.98
Cash
20.6M
Op. cash flow (ttm)
74.2M
EBITDA
111.5M
EBITDA margin
18.5%
Net debt
75.4M
Quick ratio
1.86
Interest cover
9.42
ROIC
13.1%
Goodwill / assets
30.1%
Oper. margin low 5y
10.3%
Tax rate
17.2%
Stock pay / sales
1.5%
Shares out.
7.7M
Shares Y/Y
+0.2%
Book / share
62.70
Cash / share
2.66
Sales / share
83.84
Asset turnover
0.95
Inventory turns
4.98
Days sales out.
50
Sales 3Y CAGR
+19.4%
Sales 5Y CAGR
+27.4%
EPS 3Y CAGR
+17.1%
EPS 5Y CAGR
+37.7%
Employees
4,846
Sales / employee
134K

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2016 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 602.8M +17.1% a year Net income 68.3M +27.0% a year
FY2016 revenue 146.1M · SalesRevenueNet, 0001171843-18-002024 FY2016 net income 8.0M · NetIncomeLoss, 0001171843-19-001752 146.1M FY2016 FY2017 revenue 147.8M · SalesRevenueNet, 0001171843-18-002024 FY2017 net income 9.2M · NetIncomeLoss, 0001171843-20-001695 147.8M FY2017 FY2018 revenue 190.5M · RevenueFromContractWithCustomerIncludingAssessedTax, 0001171843-21-001724 FY2018 net income 14.3M · NetIncomeLoss, 0001171843-21-001724 190.5M FY2018 FY2019 revenue 198.4M · RevenueFromContractWithCustomerIncludingAssessedTax, 0001171843-22-001850 FY2019 net income 19.8M · NetIncomeLoss, 0001171843-22-001850 198.4M FY2019 FY2020 revenue 179.4M · RevenueFromContractWithCustomerIncludingAssessedTax, 0001171843-23-001734 FY2020 net income 13.4M · NetIncomeLoss, 0001171843-23-001734 179.4M FY2020 FY2021 revenue 206.3M · RevenueFromContractWithCustomerIncludingAssessedTax, 0001171843-24-001078 FY2021 net income 15.9M · NetIncomeLoss, 0001171843-24-001078 206.3M FY2021 FY2022 revenue 353.8M · RevenueFromContractWithCustomerIncludingAssessedTax, 0001171843-25-001192 FY2022 net income 41.8M · NetIncomeLoss, 0001171843-25-001192 353.8M FY2022 FY2023 revenue 400.1M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-26-012816 FY2023 net income 44.9M · NetIncomeLoss, 0001628280-26-012816 400.1M FY2023 FY2024 revenue 504.4M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-26-012816 FY2024 net income 59.0M · NetIncomeLoss, 0001628280-26-012816 504.4M FY2024 FY2025 revenue 602.8M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-26-012816 FY2025 net income 68.3M · NetIncomeLoss, 0001628280-26-012816 602.8M FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2016 to FY2025 (9 years).

From the same starting line, FY2016 to FY2025

Revenue, net income and free cash flow, each set to 100 in FY2016. What happened, from the 10-Ks. Not a forecast.

FY2016 = 100
500 100 Revenue: $146.1M in FY2016, $602.8M in FY2025 REVENUE $602.8M · 4.1x Net income: $8.0M in FY2016, $68.3M in FY2025 NET INCOME $68.3M · 8.6x FY2016 = 100FY2021FY2025
Revenue 4.1x $146.1M to $602.8M
Net income 8.6x $8.0M to $68.3M

Growth per share, FY2015 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Earnings per share +23.6% a year FY2015 $1.05 to FY2025 $8.75, 10 years
Book value per share +14.2% a year FY2015 $14.37 to FY2025 $54.32, 10 years
500 100 EPS: $1.05 in FY2015, $8.75 in FY2025 EPS $8.75 · 8.3x Book value / share: $14.37 in FY2015, $54.32 in FY2025 BOOK VALUE / SHARE $54.32 · 3.8x FY2015 = 100FY2020FY2025

Each line is set to 100 in FY2015, so a line at 200 has doubled. What was filed, not a forecast. A line is left out when it is not above zero in every year.

Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 $8.75$54.32-
Dec 31, 2024 $7.58$44.03$7.31
Dec 31, 2023 $5.83$37.15$4.01
Dec 31, 2022 $5.45$31.00$0.52
Dec 31, 2021 $2.09$25.53$1.17
Dec 31, 2020 $1.77$23.37$2.73
Dec 31, 2019 $2.63$21.55$3.39
Dec 31, 2018 $1.93$18.90$2.14
Dec 31, 2017 $1.26$16.86$0.97
Dec 31, 2016 $1.10$15.54$0.29
Dec 31, 2015 $1.05$14.37-$0.45

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $201.0M
  • − All liabilities $231.2M
  • = Net current asset value -$30.2M
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $423.9M
  • − Goodwill $197.4M
  • − Other intangible assets $140.8M
  • = Tangible book value $85.6M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

UFPT against Health care peers

Among the 162 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+4.8%+20.2%
+19.5%43rd of 155 · median +10.5%
Net margin
-4.1%15.3%
11.8%56th of 154 · median 6.8%
Return on equity
-5.2%18.5%
15.8%43rd of 144 · median 9.2%
Debt / equity (less is better)
1.160.42
0.2016th of 108 · median 0.69
UFPT and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
UFPT UFP Technologies Inc$649.5M +19.5%28.9%11.8%15.8%-0.20
TMDX TransMedics Group, Inc.$727.6M +37.1%58.6%19.9%26.2%6.1%-
GKOS GLAUKOS Corp$690.3M +32.3%64.8%-24.6%-23.7%5.2%-
TARS Tarsus Pharmaceuticals, Inc.$682.2M +147%--102.9%-4.8%0.70
MIRM Mirum Pharmaceuticals, Inc.$670.8M +54.7%--134.8%--40.8%-
VCYT Veracyte, Inc.$581.8M +16.0%72.0%21.8%8.9%27.8%-
All 162 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement and revenue by product

From $206.3M of sales to $15.9M of profit FY2021

  • Tooling and Machinery $1.8M
  • Product $201.2M
  • Engineering and Development $3.3M
Revenue to Gross profit: $51.1MRevenue to Cost of revenue: $155.2MGross profit to Operating profit: $21.2MGross profit to Operating expenses: $29.9MOperating profit to Net profit: $15.9MOperating profit to Tax: $5.3MOperating expenses to R&D: $8.5MOperating expenses to Sales, admin & other: $21.4M Revenue: $206.3M REVENUE $206.3M +15% Y/Y Gross profit: $51.1M · 25% margin GROSS PROFIT $51.1M 25% margin · +14% Y/Y Cost of revenue: $155.2M · 75% of revenue COST OF REVENUE $155.2M 75% of revenue Operating profit: $21.2M · 10% margin OPERATING PROFIT $21.2M 10% margin · +27% Y/Y Operating expenses: $29.9M · 14% of revenue OPERATING EXPENSES $29.9M 14% of revenue Net profit: $15.9M · 8% margin NET PROFIT $15.9M 8% margin · +19% Y/Y Tax: $5.3M · 3% of revenue TAX $5.3M 3% of revenue R&D: $8.5M · 4% of revenue R&D $8.5M 4% of revenue Sales, admin & other: $21.4M · 10% of revenue SALES, ADMIN & OTHER $21.4M 10% of revenue

From $353.8M of sales to $41.8M of profit FY2022

  • Tooling and Machinery $6.3M
  • Product $342.7M
  • Engineering and Development $4.7M
Revenue to Gross profit: $90.3MRevenue to Cost of revenue: $263.5MGross profit to Operating profit: $55.4MGross profit to Operating expenses: $34.9MOperating profit to Net profit: $41.8MOperating profit to Tax & other: $13.6MOperating expenses to R&D: $9.3MOperating expenses to Sales, admin & other: $25.6M Revenue: $353.8M REVENUE $353.8M +71% Y/Y Gross profit: $90.3M · 26% margin GROSS PROFIT $90.3M 26% margin · +77% Y/Y Cost of revenue: $263.5M · 74% of revenue COST OF REVENUE $263.5M 74% of revenue Operating profit: $55.4M · 16% margin OPERATING PROFIT $55.4M 16% margin · +161% Y/Y Operating expenses: $34.9M · 10% of revenue OPERATING EXPENSES $34.9M 10% of revenue Net profit: $41.8M · 12% margin NET PROFIT $41.8M 12% margin · +163% Y/Y Tax & other: $13.6M · 4% of revenue TAX & OTHER $13.6M 4% of revenue R&D: $9.3M · 3% of revenue R&D $9.3M 3% of revenue Sales, admin & other: $25.6M · 7% of revenue SALES, ADMIN & OTHER $25.6M 7% of revenue

From $400.1M of sales to $44.9M of profit FY2023

Revenue to Gross profit: $112.2MRevenue to Cost of revenue: $287.8MGross profit to Operating profit: $57.7MGross profit to Operating expenses: $54.6MOperating profit to Net profit: $44.9MOperating profit to Tax & other: $12.7MOperating expenses to R&D: $7.2MOperating expenses to Sales, admin & other: $47.4M Revenue: $400.1M REVENUE $400.1M +13% Y/Y Gross profit: $112.2M · 28% margin GROSS PROFIT $112.2M 28% margin · +24% Y/Y Cost of revenue: $287.8M · 72% of revenue COST OF REVENUE $287.8M 72% of revenue Operating profit: $57.7M · 14% margin OPERATING PROFIT $57.7M 14% margin · +4% Y/Y Operating expenses: $54.6M · 14% of revenue OPERATING EXPENSES $54.6M 14% of revenue Net profit: $44.9M · 11% margin NET PROFIT $44.9M 11% margin · +8% Y/Y Tax & other: $12.7M · 3% of revenue TAX & OTHER $12.7M 3% of revenue R&D: $7.2M · 2% of revenue R&D $7.2M 2% of revenue Sales, admin & other: $47.4M · 12% of revenue SALES, ADMIN & OTHER $47.4M 12% of revenue

From $504.4M of sales to $59.0M of profit FY2024

Revenue to Gross profit: $146.7MRevenue to Cost of revenue: $357.7MGross profit to Operating profit: $80.9MGross profit to Operating expenses: $65.8MOperating profit to Net profit: $59.0MOperating profit to Tax & other: $21.9MOperating expenses to R&D: $10.4MOperating expenses to Sales, admin & other: $55.4M Revenue: $504.4M REVENUE $504.4M +26% Y/Y Gross profit: $146.7M · 29% margin GROSS PROFIT $146.7M 29% margin · +31% Y/Y Cost of revenue: $357.7M · 71% of revenue COST OF REVENUE $357.7M 71% of revenue Operating profit: $80.9M · 16% margin OPERATING PROFIT $80.9M 16% margin · +40% Y/Y Operating expenses: $65.8M · 13% of revenue OPERATING EXPENSES $65.8M 13% of revenue Net profit: $59.0M · 12% margin NET PROFIT $59.0M 12% margin · +31% Y/Y Tax & other: $21.9M · 4% of revenue TAX & OTHER $21.9M 4% of revenue R&D: $10.4M · 2% of revenue R&D $10.4M 2% of revenue Sales, admin & other: $55.4M · 11% of revenue SALES, ADMIN & OTHER $55.4M 11% of revenue

From $602.8M of sales to $68.3M of profit FY2025

  • Products $591.4M
  • Engineering services $6.9M
  • Tooling and Machinery $4.5M
Revenue to Gross profit: $170.4MRevenue to Cost of revenue: $432.4MGross profit to Operating profit: $92.3MGross profit to Operating expenses: $78.1MOperating profit to Net profit: $68.3MOperating profit to Tax & other: $24.0MOperating expenses to R&D: $8.6MOperating expenses to Sales, admin & other: $69.5M Revenue: $602.8M REVENUE $602.8M +20% Y/Y Gross profit: $170.4M · 28% margin GROSS PROFIT $170.4M 28% margin · +16% Y/Y Cost of revenue: $432.4M · 72% of revenue COST OF REVENUE $432.4M 72% of revenue Operating profit: $92.3M · 15% margin OPERATING PROFIT $92.3M 15% margin · +14% Y/Y Operating expenses: $78.1M · 13% of revenue OPERATING EXPENSES $78.1M 13% of revenue Net profit: $68.3M · 11% margin NET PROFIT $68.3M 11% margin · +16% Y/Y Tax & other: $24.0M · 4% of revenue TAX & OTHER $24.0M 4% of revenue R&D: $8.6M · 1% of revenue R&D $8.6M 1% of revenue Sales, admin & other: $69.5M · 12% of revenue SALES, ADMIN & OTHER $69.5M 12% of revenue

Where each $100 of sales went

FY2021
FY2022
FY2023
FY2024
FY2025
  • Cost of revenue
  • R&D
  • Sales, admin & other
  • Tax & other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2020 · 10-K XBRL, year-end balances

Return on equity 16.1% FY2020: 7.6% net income ÷ equity
Net margin 11.3% FY2020: 7.5% profit per $ of sales: 68.3M ÷ 602.8M
Asset turnover 0.92× FY2020: 0.88× sales per $ of assets: 602.8M ÷ 655.1M
Leverage 1.55× FY2020: 1.15× assets per $ of equity: 655.1M ÷ 423.9M

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin above the peer median
    11.8% vs 6.8%
  • Gross margin up over 5 years
    24.9% → 28.3%
  • Return on equity above 15%
    15.8%
  • A profit in every one of 10 years
Net margin, FY2016 to FY2025: 5.5% to 11.3%

Balance sheet

  • Interest covered more than 5 times
    Operating income is 9.4× interest expense
  • Debt smaller than equity
    Debt / equity 0.20 on the latest balance sheet (peer median 0.69)
  • Current assets cover current liabilities
    Current ratio 2.98
Debt / equity at each year end, FY2016 to FY2025: 0.01 to 0.32

Cash and shareholders

  • Free cash flow positive in every one of 9 years
    $56.9M last year
  • Share count up over 5 years
    +3.1%
  • Cash from operations above net income
    $91.9M vs $68.3M
Free cash flow, FY2016 to FY2025: 2.1M to 56.9M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

$92.9M of principal due, schedule of Sep 30, 2026

Debt

Repayment schedule

From the balance sheet in the latest 10-K or 10-Q (XBRL). When each part falls due, year by year, and the debt note's own lines are on the Debt tab.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Contract liabilities

Paid in advance $5.2M cash received before delivery, not yet recognized as revenue, Sep 30, 2026 · +7.9% on a year earlier

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

UFPT's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue602.8M
FY2016: 146.1MFY2017: 147.8MFY2018: 190.5MFY2019: 198.4MFY2020: 179.4MFY2021: 206.3MFY2022: 353.8MFY2023: 400.1MFY2024: 504.4MFY2025: 602.8M FY2017FY2019FY2021FY2023FY2025
Net income68.3M
FY2016: 8.0MFY2017: 9.2MFY2018: 14.3MFY2019: 19.8MFY2020: 13.4MFY2021: 15.9MFY2022: 41.8MFY2023: 44.9MFY2024: 59.0MFY2025: 68.3M FY2017FY2019FY2021FY2023FY2025
Free cash flow56.9M
FY2016: 2.1MFY2017: 7.1MFY2018: 15.9MFY2019: 25.5MFY2020: 20.7MFY2021: 8.9MFY2022: 4.0MFY2023: 30.8MFY2024: 56.9MFY2025: - FY2017FY2019FY2021FY2023FY2025
Free cash flow after stock pay50.1M
FY2016: 1.0MFY2017: 6.0MFY2018: 14.7MFY2019: 23.9MFY2020: 18.9MFY2021: 6.5MFY2022: 756KFY2023: 26.2MFY2024: 50.1MFY2025: - FY2017FY2019FY2021FY2023FY2025
EPS (diluted)8.75
FY2016: 1.10FY2017: 1.26FY2018: 1.93FY2019: 2.63FY2020: 1.77FY2021: 2.09FY2022: 5.45FY2023: 5.83FY2024: 7.58FY2025: 8.75 FY2017FY2019FY2021FY2023FY2025
Diluted shares7.8M
FY2016: 7.3MFY2017: 7.3MFY2018: 7.4MFY2019: 7.5MFY2020: 7.6MFY2021: 7.6MFY2022: 7.7MFY2023: 7.7MFY2024: 7.8MFY2025: 7.8M FY2017FY2019FY2021FY2023FY2025

Revenue by product or service

year to Dec 31, 2025
RevenueSharevs year before
Products 591.4M98.1% +20.3%
Engineering services 6.9M1.2% +47.1%
Tooling and Machinery 4.5M0.7% -45.9%

10-K 0001628280-26-012816, segment and revenue notes (XBRL).

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue146.1M147.8M190.5M198.4M179.4M206.3M353.8M400.1M504.4M602.8M
Cost of revenue111.5M112.4M142.1M144.4M134.7M155.2M263.5M287.8M357.7M432.4M
Gross profit34.6M35.5M48.3M54.0M44.7M51.1M90.3M112.2M146.7M170.4M
R&D1.3M5.0M10.5M8.8M8.2M8.5M9.3M7.2M10.4M8.6M
SG&A24.1M23.7M27.7M29.3M27.5M29.5M45.8M50.9M62.2M77.4M
Operating income12.2M11.7M19.6M24.7M16.7M21.2M55.4M57.7M80.9M92.3M
Interest expense69K50K1.3M674K83K39K2.8M3.6M8.1M9.8M
Pretax income12.3M11.9M18.4M23.6M16.3M21.2M52.7M53.9M73.0M82.5M
Income tax4.3M2.6M4.1M3.9M2.9M5.3M10.9M9.0M14.0M14.2M
Net income8.0M9.2M14.3M19.8M13.4M15.9M41.8M44.9M59.0M68.3M
EPS (diluted)1.101.261.932.631.772.095.455.837.588.75
Diluted shares7.3M7.3M7.4M7.5M7.6M7.6M7.7M7.7M7.8M7.8M
Depreciation & amortization5.6M5.6M7.8M8.2M8.3M8.4M11.9M11.4M14.7M19.1M
EBITDA17.9M17.3M27.4M32.9M25.0M29.6M67.3M69.1M95.6M111.5M
Gross margin23.7%24.0%25.4%27.2%24.9%24.8%25.5%28.1%29.1%28.3%
Operating margin8.4%7.9%10.3%12.5%9.3%10.3%15.7%14.4%16.0%15.3%
Net margin5.5%6.2%7.5%10.0%7.5%7.7%11.8%11.2%11.7%11.3%
Revenue growth+5.2%+1.2%+28.8%+4.2%-9.6%+15.0%+71.5%+13.1%+26.1%+19.5%
EPS growth+4.8%+14.5%+53.2%+36.3%-32.7%+18.1%+161%+7.0%+30.0%+15.4%

Cash flow

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow9.3M17.5M21.3M31.2M25.0M14.3M17.7M41.3M66.6M91.9M
Capital spending7.2M10.4M5.4M5.8M4.4M5.4M13.8M10.5M9.7M-
Free cash flow2.1M7.1M15.9M25.5M20.7M8.9M4.0M30.8M56.9M-
Stock-based pay (added back)1.1M1.1M1.2M1.6M1.8M2.4M3.2M4.6M6.8M8.9M
Free cash flow after stock pay1.0M6.0M14.7M23.9M18.9M6.5M756K26.2M50.1M-
Acquisitions--77.0M0096.2M20.7M0197.5M14.7M
Debt raised--20.0M0040.0M00125.0M0
Debt repaid1.0M856K2.9M17.1M004.0M4.0M35.1M12.5M
Investing cash flow-7.2M-10.4M-82.3M-5.8M-4.3M-101.5M1.3M-10.5M-210.2M-27.6M
Financing cash flow-559K-475K26.3M-24.9M-285K74.0M-25.9M-30.0M152.4M-58.2M

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)1.1M1.1M1.2M1.6M1.8M2.4M3.2M4.6M6.8M8.9M
Stock-based pay / revenue0.7%0.7%0.6%0.8%1.0%1.2%0.9%1.2%1.4%1.5%
Operating lease cost---1.2M1.2M1.3M2.6M3.1M3.9M5.0M
Operating lease cash paid---1.2M1.2M1.3M2.5M3.0M3.8M5.4M
Finance lease principal paid--0011K29K63K63K73K63K
Right-of-use assets--03.0M2.1M9.1M-13.4M16.1M18.8M
Operating lease liabilities--4.1M3.1M2.1M9.1M13.2M13.9M16.6M19.2M
Finance lease liabilities--0-101K273K215K156K95K34K

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/UFPT/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.